How to treat elderly CLL patients in the light of novel therapies
Trial results and drug combinations for bortezomib in multiple myeloma
From Structure to Function to Clinical Outcome
Why do many MM patients relapse after being treated with targeted therapy?
Allogeneic transplant in multiple myeloma: who should receive it and the future of transplant
Heinz Ludwig et al.